Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2025 Earnings Call Transcript

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Q4 2025 Earnings Call Transcript February 26, 2026

Crinetics Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.30575, expectations were $-1.37.

Operator: Welcome to Crinetics Pharmaceuticals, Inc. Fourth Quarter and Full Year 2025 Financial Results Conference Call. At this time, all participants are in listen-only mode. Following management’s prepared remarks, we will hold a question-and-answer session. In order to ask a...